Literature DB >> 11904134

Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.

Daniel Umbricht1, Rene Koller, Franz X Vollenweider, Liselotte Schmid.   

Abstract

BACKGROUND: Previous studies indicate that mismatch negativity (MMN)-a preattentive auditory event-related potential (ERP)-depends on NMDA receptor (NMDAR) functioning. To explore if the strength of MMN generation reflects the functional condition of the NMDAR system in healthy volunteers, we analyzed correlations between MMN recorded before drug administration and subsequent responses to the NMDAR antagonist ketamine or the 5-HT2a agonist psilocybin.
METHODS: In two separate studies, MMN was recorded to both frequency and duration deviants prior to administration of ketamine or psilocybin. Behavioral and subjective effects of ketamine and psilocybin were assessed with the Brief Psychiatric Rating Scale and the OAV Scale-a rating scale developed to measure altered states of consciousness. Correlations between ERP amplitudes (MMN, N1, and P2) and drug-induced effects were calculated in each study group and compared between them.
RESULTS: Smaller MMN to both pitch and duration deviants was significantly correlated to stronger effects during ketamine, but not psilocybin administration. No significant correlations were observed for N1 and P2.
CONCLUSIONS: Smaller MMN indicates a NMDAR system that is more vulnerable to disruption by the NMDAR antagonist ketamine. MMN generation appears to index the functional state of NMDAR-mediated neurotransmission even in subjects who do not demonstrate any psychopathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904134     DOI: 10.1016/s0006-3223(01)01242-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  81 in total

Review 1.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 2.  How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control.

Authors:  J Leon Kenemans; Seppo Kähkönen
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 3.  Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.

Authors:  Daniel C Javitt
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

4.  Bi-directional modulation of somatosensory mismatch negativity with transcranial direct current stimulation: an event related potential study.

Authors:  Jui-Cheng Chen; Dorothea Hämmerer; Kevin D'Ostilio; Elias P Casula; Louise Marshall; Chon-Haw Tsai; John C Rothwell; Mark J Edwards
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

5.  Gray matter deficits, mismatch negativity, and outcomes in schizophrenia.

Authors:  P E Rasser; U Schall; J Todd; P T Michie; P B Ward; P Johnston; K Helmbold; V Case; A Søyland; P A Tooney; P M Thompson
Journal:  Schizophr Bull       Date:  2009-06-26       Impact factor: 9.306

6.  Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.

Authors:  Neal R Swerdlow; Savita Bhakta; Hsun-Hua Chou; Jo A Talledo; Bryan Balvaneda; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2015-06-11       Impact factor: 7.853

7.  Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.

Authors:  Danielle Impey; Ashley Baddeley; Renee Nelson; Alain Labelle; Verner Knott
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

8.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Authors:  Sumie Leung; Rodney J Croft; Valérie Guille; Kirsty Scholes; Barry V O'Neill; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

Review 9.  Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Authors:  Daniel C Javitt; Robert A Sweet
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

10.  Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.

Authors:  Sumie Leung; Rodney J Croft; Barry V O'Neill; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-10-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.